JUN ZHAO
Social Work at Broadway, New York, NY
License number
New York 094373
Category
Social Work
Type
Social Worker
Address
Address
2
936 Broadway, New York, NY 10010
11201 75Th Ave APT 3, Flushing, NY 11375
11201 75Th Ave APT 3, Flushing, NY 11375
Phone
(212) 879-4900
(216) 410-0719
(216) 410-0719
Personal information
See more information about JUN ZHAO at radaris.comName
Address
Phone
5632 Van Cleef St, Corona, NY 11368
5646 135Th St, Flushing, NY 11355
53 Menahan St, Brooklyn, NY 11221
4515 Colden St APT 2H, Flushing, NY 11355
4221 149Th St, Flushing, NY 11355
Professional information
See more information about JUN ZHAO at trustoria.com
Director Of Risk Technology At Taconic Capital Advisors Lp
Director Of Risk Technology At Taconic Capital Advisors Lp
Position:
Director of Risk Technology at Taconic Capital Advisors LP
Location:
Greater New York City Area
Industry:
Financial Services
Work:
Taconic Capital Advisors LP
since Mar 2008
-
Director of Risk Technology
FFTW
Jan 1999 - Mar 2008
-
Director of Investment Analytics
Education:
University of Greenwich 1993 - 1996
PhD, Computer Science The University of Sheffield 1992 - 1993
MSc, Expert System Engineering Jilin University 1980 - 1984
BS, Engineering
PhD, Computer Science The University of Sheffield 1992 - 1993
MSc, Expert System Engineering Jilin University 1980 - 1984
BS, Engineering
Controller At Tlc Beatrice
Controller At Tlc Beatrice
Position:
Controller at TLC Beatrice
Location:
Greater New York City Area
Industry:
Accounting
Work:
TLC Beatrice
-
Controller
Education:
The University of Akron 1997 - 1999
Student At Rutgers, The State University Of New Jersey-New Brunswick
Student At Rutgers, The State University Of New Jersey-New Brunswick
Location:
Greater New York City Area
Industry:
Accounting
Education:
Rutgers, The State University of New Jersey-New Brunswick 1994 - 1999
Organic Compounds
Organic Compounds
US Patent:
2014000, Jan 2, 2014
Filed:
Sep 6, 2013
Appl. No.:
14/020016
Inventors:
Jun ZHAO - New York NY, US
Hailin ZHENG - New York NY, US
Lawrence P. WENNOGLE - New York NY, US
Hailin ZHENG - New York NY, US
Lawrence P. WENNOGLE - New York NY, US
Assignee:
INTRA-CELLULAR THERAPIES, INC - New York NY
International Classification:
C07D 487/14, A61K 45/06, A61K 31/5025
US Classification:
514171, 544247, 514257
Abstract:
Optionally substituted 3-(thio, sulfinyl or sulfonyl)-7,8-dihydro-(1H or 2H)-imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5H)-one or a substituted 3-(thio, sulfinyl or sulfonyl)-7,8,9-trihydro-(1H or 2H)-pyrimido[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5H)-one compounds or Compounds of Formula (I), processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.
Organic Compounds
Organic Compounds
US Patent:
8536159, Sep 17, 2013
Filed:
Dec 7, 2009
Appl. No.:
13/133033
Inventors:
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Hailin Zeng - New York NY, US
Lawrence Wennogle - New York NY, US
Jun Zhao - New York NY, US
Hailin Zeng - New York NY, US
Lawrence Wennogle - New York NY, US
Assignee:
Intra-Cellular Therapies, Inc. - New York NY
International Classification:
A61K 31/565, A61K 31/519, A61K 31/57, C07D 487/14
US Classification:
514171, 514257, 544247
Abstract:
Optionally substituted 3-(thio, sulfonyl or sulfonyl)-7,8-dihydro-(1H or 2H)-imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5H)-one or a substituted 3-(thio, sulfinyl or sulfonyl)-7,8,9-trihydro-(1H or 2H)-pyrimido[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5H)-one compounds or Compounds of Formula (I), processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.
Organic Compounds
Organic Compounds
US Patent:
2013033, Dec 19, 2013
Filed:
May 31, 2011
Appl. No.:
13/701284
Inventors:
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Jun Zhao - New York NY, US
Assignee:
INTRA-CELLULAR THERAPIES, INC. - New York NY
International Classification:
C07D 487/04, A61K 45/06, A61K 31/519
US Classification:
514171, 544262, 5142621
Abstract:
The present invention relates to (1- or 2- and/or 5 and/or 7-substituted)-(3-oxy)-(4H, 4-imino, 4-thioxo or 4-oxo)-pyrazolo[3,4-d]pyrimidin-6-ones, e.g., a compound of formula II as described below, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them. Of particular interest are novel compounds useful as inhibitors of phosphodiesterase 1 (PDE1), e.g., in the treatment of diseases involving disorders of the dopamine D1 receptor intracellular pathway, such as Parkinson's disease, depression, narcolepsy, damage to cognitive function, e.g., in schizophrenia, or disorders that may be ameliorated through enhanced progesterone-signaling pathway, e.g., female sexual dysfunction.
Organic Compounds
Organic Compounds
US Patent:
2011028, Nov 17, 2011
Filed:
Dec 7, 2009
Appl. No.:
13/133096
Inventors:
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Hailin Zheng - New York NY, US
Lawrence P. Wennogle - New York NY, US
Jun Zhao - New York NY, US
Hailin Zheng - New York NY, US
Lawrence P. Wennogle - New York NY, US
International Classification:
A61K 31/565, A61K 31/519, A61K 31/57, A61P 25/16, A61P 25/14, A61P 25/28, A61P 25/24, A61P 25/00, A61P 25/22, A61P 25/20, A61P 25/30, A61P 9/00, A61P 9/12, A61P 15/00, A61P 11/06, A61P 11/00, A61P 11/02, A61P 29/00, A61P 37/06, A61P 43/00, A61P 5/14, A61P 15/06, A61P 15/08, A61P 19/10, A61P 35/00, A61P 27/06, A61P 25/18, C07D 487/04
US Classification:
514171, 544262, 5142621
Abstract:
Optionally substituted (5- or 7-amino)-3,4-dihydro-(optionally 4-oxo, 4-thioxo or 4-imino)-1H-pyrrolo[3,4-d]pyrimidin-2(6H)-ones, Compounds of Formula I, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.
Organic Compounds
Organic Compounds
US Patent:
2013033, Dec 12, 2013
Filed:
May 31, 2011
Appl. No.:
13/701244
Inventors:
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Jun Zhao - New York NY, US
Assignee:
INTRA-CELLULAR THERAPIES, INC. - New York NY
International Classification:
A61K 31/519, A61K 45/06, A61K 31/5575, C07D 487/14
US Classification:
514171, 544247, 514257
Abstract:
Optionally substituted (1- or 3-oxy)-4,5,7,8-tetrahydro-(optionally 4-oxo, 4-thioxo or 4-imino)-2H-imidazo[1,2-a]pyrrolo[3,4-e]pyrimidine or (1- or 3-oxy)-4,5,7,8,9-pentahydro-(optionally 4-oxo, 4-thioxo or 4-imino)-2H-pyrimido[1,2-a]pyrrolo[3,4-e]pyrimidine compounds, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising the same.
Organic Compounds
Organic Compounds
US Patent:
8633180, Jan 21, 2014
Filed:
Dec 7, 2009
Appl. No.:
13/133082
Inventors:
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Hailin Zeng - New York NY, US
Lawrence Wennogle - New York NY, US
Jun Zhao - New York NY, US
Hailin Zeng - New York NY, US
Lawrence Wennogle - New York NY, US
Assignee:
Intra-Cellular Therapies, Inc. - New York NY
International Classification:
A61K 31/565, A61K 31/57, A61K 31/519, C07D 487/14
US Classification:
514171, 514257, 544247
Abstract:
Optionally substituted 4,5,7,8-tetrahydro-(optionally 4-thioxo or 4-imino)-(1H or 2H)-imidazo[1,2-a]pyrazolo[4,3-e]pyrimidine or 4,5,7,8,9-pentahydro-(optionally 4-thioxo or 4-imino)-(1H or 2H)-pyrimido[1,2-a]pyrazolo[4,3-e]pyrimidine compounds or Compounds of Formula (I), processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.